European drugmakers to disclose 2017 payments to healthcare professionals

20 June 2018
efpia-big

As part of an agreement called the EFPIA Code, European drugmakers will in the next ten days release details of payments to healthcare professionals made in 2017.

The data will include payments such sponsorship to attend meetings, speaker fees, consultancy and advisory boards.

The European Federation of Pharmaceutical Industries and Associations (EFPIA) says that “bringing greater transparency to these already well-regulated and essential relationships is about strengthening the basis for collaboration in the future.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical